Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells

Journal of Immunology

Volumn 180, Issue 10, 2008, Pages 6593-6603

  Hu, Min ^a   Watson, Debbie ^a   Zhang, Geoff Y ^a   Graf, Nicole ^a   Wang, Yuan M ^a   Sartor, Mary ^a   Howden, Brian ^b   Fletcher, Jeffrey ^a   Alexander, Stephen I ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Australia Microsurgical Consultants   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CELL DIVISION; CELL EXPANSION; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FIBROSIS; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SURVIVAL TIME; ALLOTRANSPLANTATION; ANIMAL; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENETICS; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; METHODOLOGY; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNE TOLERANCE; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME; TRANSPLANTATION, HOMOLOGOUS;

EID: 45549095345     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.10.6593     Document Type: Article

References (57)

1. Avery, R. K. 2003. Cardiac-allograft vasculopathy. N. Engl. J. Med. 349: 829-830.
2. Tanaka, M., K. Sydow, F. Gunawan, J. Jacobi, P. S. Tsao, R. C. Robbins, and J. P. Cooke. 2005. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation 112: 1549-1556.
3. Chen, J., Q. He, H. Xu, L. Su, J. Zhang, and S. Xiong. 2004. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts. Transplant Immunol. 13: 283-288.
4. Sho, M, S. E. Sandner, N. Najafian. A. D. Salama, V. Dong, A. Yamada, K. Kishimoto, H. Harada, I. Schmitt, and M. H. Sayegh. 2002. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann. Surg. 236: 667-675.
5. + T cells prolong cardiac allograft survival in rats. J. Heart Lung Transplant. 24: 2153-2159.
6. Lechler, R. I., O. A. Garden, and L. A. Turka. 2003. The complementaty roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 3: 147-158.
7. Sykes, M. 2001. Mixed chimerism and transplant tolerance. Immunity 14: 417-424.
8. Nikolic, B., and M. Sykes. 1997. Mixed hematopoietic chimerism and transplantation tolerance. Immunol. Res. 16: 217-228.
9. Wekerle, T., M. H. Sayegh, J. Hill, Y. Zhao, A. Chandraker, K. G. Swenson, G. Zhao, and M. Sykes. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187: 2037-2044.
10. Walsh, P. T., D. K. Taylor, and L. A. Turka. 2004. Tregs and transplantation tolerance. J. Clin. Invest. 114: 1398-1403.
11. Wells, A. D., X. C. Li, T. B. Strom, and L. A. Turka. 2001. The role of peripheral T-cell deletion in transplantation tolerance. Philos. Trans. R. Soc. London B Biol. Sci. 356: 617-623.
12. Rothstein, D. M., and M. H. Sayegh. 2003. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol. Rev. 196: 85-108.
13. + regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 105: 4871-4877.
14. + T regulatory cell induction and function in transplant recipients after CD 154 blockade is TLR4 independent. J. Immunol. 176: 5988-5994.
15. Kataoka, M., J. A. Margenthaler, G. Ku, and M. W. Rye. 2003. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation. J. Immunol. 171: 204-211.
16. Buhler, L. H., T. R. Spitzer, M. Sykes, D. H. Sachs, F. L. Delmonico, N. Tolkoff-Rubin, S. L. Saidman, R. Sackstein, S. McAfee, B. Dey, et al. 2002. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74: 1405-1409.
17. Zhang, Q. W., Y. Tomita, G. Matsuzaki, I. Shimizu, T. Iwai, S. Okano, R. Minagawa, Y. Nakashima, K. Sueishi, K. Nomoto, and H. Yasui. 2002. Heart allograft tolerance without development of posttransplant cardiac allografl vasculopathy in chimerism-based, drug-induced tolerance. Transplantation 73: 652-656.
18. Shirasugi, N., A. B. Adams, M. M. Durham, A. E. Lukacher, H. Xu, P. Rees, S. R. Cowan, M. A. Williams, T. C. Pearson, and C. P. Larsen. 2002. Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens. J. Immunol. 169: 2677-2684.
19. Ho, V. T., and R. J. Soiffer. 2001. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98: 3192-3204.
20. Spitzer, T. R. 2001. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 27: 893-898.
21. Sykes, M. 1993. Novel approaches to the control of graft versus host disease. Curr. Opin. Immunol. 5: 774-781.
22. Pietra, B. A., A. Wiseman, A. Bolwerk, M. Rizeq, and R. G. Gill. 2000. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J. Clin. Invest. 106: 1003-1010.
23. Grazia, T. J., B. A. Pietra, Z. A. Johnson, B. P. Kelly, R. J. Plenter, and R. G. Gill. 2004. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J. Immunol. 172: 7451-7458.
24. Onodera, K., M. Lehmann, E. Akalin, H. D. Volk, M. H. Sayegh, and J. W. Kupiec-Weglinski. 1996. Induction of "infectious" tolerance to MHC-in-cotnpatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J. Immunol. 157: 1944-1950.
25. Pearson, T. C, C. R. Darby, and K. J. Wood. 1992. Successful secondary hete-rotopic cardiac transplantation in the mouse. Transplantation 53: 701-703.
26. Orosz, C. G., E. Wakely, S. D. Bergese, A. M. VanBuskirk, R. M. Ferguson, D. Mullet, G. Apseloff, and N. Gerber. 1996. Prevention of murine cardiac al-lograft rejection with gallium nitrate: comparison with anti-CD4 monoclonal antibody. Transplantation 61: 783-791.
27. + cells are essential for allorejection. J. Exp. Med. 184: 2013-2018.
28. Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171: 131-137.
29. Suchin, E. J., P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, and L. A. Turka. 2001. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J. Immunol. 166: 973-981.
30. Ford, W. L., S. J. Simmonds, and R. C. Atkins. 1975. Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex. J. Exp. Med. 141: 681-696.
31. Matzinger, P., and M. J. Bevan. 1977. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol. 29: 1-5.
32. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorccog-nition. Annu. Rev. Immunol. 11: 385-402.
33. Ema, H., A. Cumano, and P. Kourilsky. 1997. TCR-beta repertoire development in the mouse embryo. J. Immunol. 159: 4227-4232.
34. LaRocque, R., and M. A. Robinson. 1996. Diversity in the human T cell receptor beta chain. Hum. Immunol. 48: 3-11.
35. Heslan, J. M., G. Beriou, J. B. Le Luduec, C. Guillonneau, I. Anegon, J. P. Soulillou, M. C. Cuturi, and E. Chiffoleau. 2005. Accumulation of T cells with potent regulatory properties and restricted Vβ 7-TCR rearrangements in tolerated allografts. Transplantation 80: 1476-1484.
36. Mohiuddin, M., V. Ruggiero, Z. Shen, and V. J. DiSesa. 1996. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bml cardiac grafts. J. Thorac. Cardiovasc. Surg. 112: 310-313.
37. Nordon, R. E., M. Nakamura, C. Ramirez, and R. Odell. 1999. Analysis of growth kinetics by division tracking. Immunol. Cell Biol. 77: 523-529.
38. von Horsten, S., A. Helfritz, S. Kuhlmann, H. Nave, T. Tschemig, R. Pabst, S. Ben Eliyahu, D. Meyer, R. E. Schmidt, and C. Schmitz. 2000. Stereological quantification of carboxyfluorescein-labeled rat lung metastasis: a new method for the assessment of natural killer cell activity and tumor adhesion in vivo and in situ. J. Immunol. Methods 239: 25-34.
39. Weston, S. A., and C. R. Parish. 1990. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133: 87-97.
40. + T cells using 5- (and 6-)carboxyfluorescein diacetate succin-imidyl ester prolongs skin allograft survival. J. Immunol. 173: 6574-6582.
41. Corry, R. J., H. J. Winn, and P. S. Russell. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16: 343-350.
42. LeFranc, M. 2001. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 2001. 29: 207-209.
43. Walters, G., and S. I. Alexander. 2004. T cell receptor BV repertoires using real time PCR: a comparison of SYBR green and a dual-labelled HuTrec fluorescent probe. J. Immunol. Methods 294: 43-52.
44. Hu, M., G. Y. Zhang, G. Walters, M. Sartor, D. Watson, J. F. Knight, and S. I. Alexander. 2004. Matching T-cell receptors identified in renal biopsies and urine at the lime of acute rejection in pediatric renal transplant patients. Am. J. Transplant. 4: 1859-1868.
45. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183.
46. Bach, F. H., and N. K. Voynow. 1966. One-way stimulation in mixed leukocyte cultures. Science 153: 545-547.
47. + T cell-mediated cardiac allograft rejection. J. Immunol. 167: 5457-5463.
48. + T cell function but not expansion. Nat. Immunol. 3: 1208-1213.
49. Julius, B. K., C. 11. Attenhofer Jost, G. Sutsch, H. P. Brunner, A. Kuenzli, P. R. Vogt, M. Turina, O. M. Hess, and W. Kiowski. 2000. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation 69: 847-853.
50. Lange, V., A. Renner, M. Sagstetter, H. Harms, and O. Elert. 2006. Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects? Transplantation 82: 234-240.
51. Libby, P., and J. S. Pober. 2001. Chronic rejection. Immunity 14: 387-397.
52. Billingham, M. E. 1994. Pathology and etiology of chronic rejection of the heart. Clin. Transplant. 8: 289-292.
53. Uehara, S., C. M. Chase, R. B. Colvin, J. C. Madsen, and P. S. Russell. 2006. T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism. Transplant. Proc. 38:3169-3171.
54. Kedl, R. M., W. A. Rees, D. A. Hildeman, B. Schaefer, T. Mitchell, J. Kappler, and P. Marrack. 2000. T cells compete for access to antigen-bearing antigen-presenting cells. 7. Exp. Med. 192: 1105-1113.
55. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92.
56. Lechler, R. I., M. Sykes, A. W. Thomson, and L. A. Turka. 2005. Organ transplantation: how much of the promise has been realized? Nat. Med. 11: 605-613.
57. Adams, A. B., T. C. Pearson, and C. P. Larsen. 2003. Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196: 147-160.